Drs. Anita Mahadevan-Jansen, Peter Konrad, Duco Jansen and Chris Kao (not pictured) have developed a new technology enabling light-based stimulation of neurological tissue, which has been licensed to Aculight Corporation.

Dr. Benoit Dawant demonstrates the use of the StarFix platform that is used in deep brain stimulation surgeries. Dawant has developed a software technology that helps custom design this product for each individual patient.

Drs. Michael Fitzpatrick, Robert Labadie and Benoit Dawant (not pictured) have developed a percutaneous cochlear implantation that simplifies the currently used method to restore hearing in patients suffering from sensorineural hearing loss.

Dr. Bob Galloway has developed a new technology for image-guided surgery in soft tissue, which was licensed to Pathfinder Therapeutics, a Vanderbilt start-up company that is the pioneer in the field of Navigated Abdominal Surgery (NAS).

Dr. Jeffrey Conn is the Lee E. Limbird Professor of Pharmacology and founding Director of the Program in Drug Discovery. His current research is focused on development of novel treatment strategies for schizophrenia, Parkinson’s disease and other brain disorders."The Office of Technology Transfer and Enterprise Development has demonstrated a solid commitment to deploying the resources necessary to make our drug discovery efforts translate into numerous licensing and research relationships."

— Dr. Jeffrey Conn

Dr. Essam Enan has developed a range of pesticides made from natural ingredients, which makes them environmentally friendly, as well as harmless to humans and animals. TyraTech, a Vanderbilt start-up company, was formed in 2004 based on Enan's technology."When I first brought my ideas for how to develop new naturally-occurring insect control products to OTTED, they took a real interest in the concept, even at such an early developmental stage. With their support and guidance, a new company, TyraTech, Inc., was formed and funded. The first TyraTech product is now available to the public, and I do not believe this would have been possible without the high level of interaction with OTTED."

— Dr. Essam Enan